Vanguard Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.69M Sell
8,482,873
-436,170
-5% -$396K ﹤0.01% 3040
2025
Q1
$4.03M Buy
8,919,043
+286,115
+3% +$129K ﹤0.01% 3258
2024
Q4
$4.34M Buy
8,632,928
+31,933
+0.4% +$16.1K ﹤0.01% 3329
2024
Q3
$7.78M Buy
8,600,995
+127,028
+1% +$115K ﹤0.01% 3081
2024
Q2
$8.45M Buy
8,473,967
+100,196
+1% +$99.9K ﹤0.01% 3014
2024
Q1
$12.4M Sell
8,373,771
-10,916
-0.1% -$16.2K ﹤0.01% 2848
2023
Q4
$9.14M Buy
8,384,687
+72,355
+0.9% +$78.9K ﹤0.01% 2997
2023
Q3
$9.81M Buy
8,312,332
+1,150,633
+16% +$1.36M ﹤0.01% 2891
2023
Q2
$10.1M Buy
7,161,699
+656,761
+10% +$926K ﹤0.01% 2938
2023
Q1
$9.76M Buy
6,504,938
+397,884
+7% +$597K ﹤0.01% 2947
2022
Q4
$7.15M Buy
6,107,054
+155,561
+3% +$182K ﹤0.01% 3122
2022
Q3
$6.73M Hold
5,951,493
﹤0.01% 3156
2022
Q2
$9.4M Sell
5,951,493
-5,438
-0.1% -$8.59K ﹤0.01% 3023
2022
Q1
$9.17M Sell
5,956,931
-4,724
-0.1% -$7.27K ﹤0.01% 3198
2021
Q4
$14.6M Buy
5,961,655
+5,021
+0.1% +$12.3K ﹤0.01% 3013
2021
Q3
$15M Sell
5,956,634
-442,181
-7% -$1.11M ﹤0.01% 3013
2021
Q2
$18.2M Buy
6,398,815
+838,759
+15% +$2.39M ﹤0.01% 2897
2021
Q1
$13.1M Sell
5,560,056
-647,678
-10% -$1.52M ﹤0.01% 3007
2020
Q4
$10.9M Buy
6,207,734
+979,677
+19% +$1.72M ﹤0.01% 2948
2020
Q3
$4.9M Buy
5,228,057
+1,099
+0% +$1.03K ﹤0.01% 3156
2020
Q2
$4.55M Sell
5,226,958
-252,750
-5% -$220K ﹤0.01% 3144
2020
Q1
$4.54M Buy
5,479,708
+11,808
+0.2% +$9.78K ﹤0.01% 3008
2019
Q4
$4.87M Sell
5,467,900
-8,967
-0.2% -$7.98K ﹤0.01% 3183
2019
Q3
$5.37M Buy
5,476,867
+166,477
+3% +$163K ﹤0.01% 3114
2019
Q2
$5.84M Buy
5,310,390
+123,047
+2% +$135K ﹤0.01% 3110
2019
Q1
$6.8M Buy
5,187,343
+3,193,430
+160% +$4.18M ﹤0.01% 3013
2018
Q4
$1.82M Sell
1,993,913
-3,112,666
-61% -$2.84M ﹤0.01% 3407
2018
Q3
$10.5M Buy
5,106,579
+31,822
+0.6% +$65.4K ﹤0.01% 2891
2018
Q2
$9.15M Buy
5,074,757
+276,192
+6% +$498K ﹤0.01% 2946
2018
Q1
$11.3M Buy
4,798,565
+99,293
+2% +$234K ﹤0.01% 2776
2017
Q4
$8.84M Buy
4,699,272
+218,713
+5% +$411K ﹤0.01% 2879
2017
Q3
$11.1M Buy
4,480,559
+273,513
+7% +$680K ﹤0.01% 2758
2017
Q2
$11.6M Buy
4,207,046
+610,965
+17% +$1.68M ﹤0.01% 2703
2017
Q1
$10.9M Buy
3,596,081
+472,142
+15% +$1.43M ﹤0.01% 2726
2016
Q4
$9.87M Buy
3,123,939
+118,427
+4% +$374K ﹤0.01% 2750
2016
Q3
$10.3M Buy
3,005,512
+234,065
+8% +$799K ﹤0.01% 2672
2016
Q2
$6.33M Buy
2,771,447
+467,374
+20% +$1.07M ﹤0.01% 2858
2016
Q1
$5.79M Sell
2,304,073
-1,367
-0.1% -$3.43K ﹤0.01% 2890
2015
Q4
$7.63M Buy
2,305,440
+169,613
+8% +$561K ﹤0.01% 2779
2015
Q3
$5.17M Buy
2,135,827
+249,362
+13% +$604K ﹤0.01% 2953
2015
Q2
$5.53M Buy
1,886,465
+87,930
+5% +$258K ﹤0.01% 2967
2015
Q1
$7.21M Buy
1,798,535
+56,513
+3% +$227K ﹤0.01% 2808
2014
Q4
$5.25M Buy
1,742,022
+90,737
+5% +$273K ﹤0.01% 2880
2014
Q3
$4.18M Buy
1,651,285
+143,452
+10% +$363K ﹤0.01% 2930
2014
Q2
$3.71M Buy
1,507,833
+23,909
+2% +$58.9K ﹤0.01% 2988
2014
Q1
$3.94M Buy
1,483,924
+127,014
+9% +$337K ﹤0.01% 2945
2013
Q4
$3.94M Buy
1,356,910
+255,179
+23% +$741K ﹤0.01% 2918
2013
Q3
$3.38M Buy
1,101,731
+18,231
+2% +$55.9K ﹤0.01% 2927
2013
Q2
$3.46M Buy
+1,083,500
New +$3.46M ﹤0.01% 2861